Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
REVENUES-RELATED PARTY $ 174,999 $ 245,864 $ 524,997 $ 672,556
REVENUES-OTHER 16,200 16,200
Total Revenues 191,199 245,864 541,197 672,556
EXPENSES        
Payroll and related expenses 299,222 311,499 928,492 1,186,736
Professional fees 173,279 63,228 327,961 285,825
General and administrative 30,446 30,279 173,067 133,644
Research and development expenses 96,943 206,943
Total Expenses 599,890 405,006 1,636,463 1,606,205
LOSS FROM OPERATIONS (408,691) (159,142) (1,095,266) (933,649)
OTHER INCOME (EXPENSE)        
Financing costs including interest (168,899) (136,954) (474,185) (413,104)
Change in fair value of convertible bridge notes (1,343,237) 735,805 (1,666,422) 490,079
Loss on equity method investment (21,588)
Loss on debt extinguishment (503,762) (503,762)
Other miscellaneous income 5,000
Total Other Income (Expense) (2,015,898) 598,851 (2,639,369) 55,387
LOSS BEFORE INCOME TAXES (2,424,589) 439,709 (3,734,635) (878,262)
INCOME TAXES
NET INCOME (LOSS) (2,424,589) 439,709 (3,734,635) (878,262)
PREFERRED STOCK        
Series A convertible contractual dividends (9,074) (9,074) (26,366) (26,926)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,433,663) $ 430,635 $ (3,761,001) $ (905,188)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC AND DILUTED $ (1.03) $ 0.21 $ (1.64) $ (0.44)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED 2,365,613 2,079,898 2,296,748 2,079,898